education

Indiana University School of Law (J.D., 1981), with honors
Purdue University (B.S., 1978), with distinction

related practices

related industries

bar admissions

Florida

court admissions

Florida State Courts
United States Supreme Court
U.S. Court of Appeals, Eleventh Circuit
U.S. District Court, Middle District of Florida
U.S. District Court, Northern District of Florida
U.S. District Court, Southern District of Florida

Edward W. Gerecke

Shareholder

egerecke@carltonfields.com

Tampa

T: 813.229.4306

F: 813.229.4133

vCard

PDF

Ed Gerecke is certified as a Civil Trial Attorney by the National Board of Trial Advocates. He has extensive experience in prescription drug, medical device and OTC product defense. Mr. Gerecke also practices general products liability and personal injury defense.

+ Expand All

Representative Experience

Layton v. SmithKline Beecham Corp., No. 05-CA-007440, 2012 WL 4983778 (Fla. Cir. Ct. 13th Jud. Cir. Oct. 16, 2012) (an evidentiary hearing is not required to determine entitlement to attorneys’ fees and costs based upon a proposal for settlement).
Wolicki-Gables v. Arrow Int'l, Inc., -- F.3d ---, 2011 WL 780684 (11th Cir. Mar. 8, 2011).
Chapman v. DePuy Orthopedics, Inc., No. 8:09-cv-1835-T-33TGW, 2011 WL 149329 (M.D. Fla. Jan. 18, 2011).
Levine v. Wyeth Inc., 684 F. Supp. 2d 1338 (M.D. Fla. 2010).
Lake v. Tenneco, Inc., No. 8:06-cv-1462-T-24 TBM, 2009 WL 2870503 (M.D. Fla. Sept. 3, 2009).
Lake v. Tenneco, Inc., No. 8:06-cv-1462-T-24 TBM, 2009 WL 2914234 (M.D. Fla. June 26, 2009) (expert's cited sources must support his conclusions and opinions).
Wolicki-Gables v. Arrow Int'l, Inc., 2009 WL 2190069 (M.D. Fla.).
Wolicki-Gables v. Arrow Int'l, Inc., 2008 WL 2773721 (M.D. Fla.).
Colville v. Pharmacia, 565 F. Supp. 2d 1314 (N.D. Fla. 2008).
Lake v. Tenneco, 2007 WL 4482567 (M.D. Fla.).
Vincent v. C.R. Bard, Inc., 944 So. 2d 1083 (Fla. 2d DCA 2005).
Sharp v. Wyeth, 2006 WL 515532 (Fla. Cir. Ct.).
Marzullo v. Crosman Corp., 289 F. Supp. 2d 1337 (M.D. Fla. 2003).
Marking v. Novartis, 2002 WL 32255405 (S.D. Fla. 2002).
Savage v. Danek Medical, Inc., 31 F. Supp. 2d 980 (M.D. Fla. 1999), aff'd 202, F.3d 288 (11th Cir. 1999).
King v. Cutter Laboratories, 714 So. 2d 351 (Fla. 1998).
Walls v. Armour Pharmaceutical Co., 53 F.3d 1184 (11th Cir. 1995).
Reynard v. NEC Corp., 887 F. Supp. 1500 (M.D. Fla. 1995).
Jones v. Upjohn Co., 661 So. 2d 356 (Fla. 2d DCA 1995).
Chikovsky v. Ortho Pharmaceutical Co., 832 F. Supp. 341 (S.D. Fla. 1993).
Mitchell v. VLI Corp., 786 F. Supp. 966 (M.D. Fla. 1992).
Adams v. G.D. Searle & Co., 576 So. 2d 728 (Fla. 2d DCA 1991), rev. den., 589 So. 2d 290 (1991).

Publications

10.01.2012	Co-Author, “Mensing: Effects and Opportunities,” For the Defense (October 2012).
10.04.2010	Co-Author, "Sales Reps in the OR: The Hunt for Non-Preempted Claims," DRI's For the Defense (October 2010).
02.03.2010	Client Alert: 2009 Top 10 Pharma Decisions from Florida and the Eleventh Circuit (February 2010).
01.01.2009	Co-Author, 50-State Survey (Florida), “Plaintiff’s Medical Care and Treatment—Discovery and Evidentiary Issues,” American Bar Association Products Liability Committee of the Section of Litigation (2009).
07.02.2007	Client Alert: Pharmaceutical and Medical Device Alert - Beale v. Biomet, Inc.
2007	Co-Author, "Florida Law Regarding Punitive Damages Claims," ABA Section of Litigation, Products Liability Committee, Pharmaceutical Subcommittee's 50-State-Survey (2007).
04.22.2006	Co-Author, “Design Defects in Prescription Medical Products: Section 6(c) of the Third Restatement,” For the Defense (April 2006).
12.12.2002	Editor, "State-by-State Summary of the Learned Intermediary Doctrine," ABA (July 1993).
12.01.2001	Co-Author, “Demanding Reliability from Experts Under Florida Law,” Trial Advocate Quarterly (selected by FDLA for the Trial Advocate Award for best article) (Winter 2001).
01.01.2001	"State-by-State Summary of the Law on FDCA - Related Causes Of Action," Florida Section, ABA (2001).
10.09.2000	"Halting Regulation Through Litigation," The National Law Journal (October 2000).
08.01.1999	"State-by-State Summary of the Law on Liability for Off Label Use of Drugs and Medical Devices,” ABA (August 1999).
09.01.1998	"Market Share Theory: Limited Logic Meets Some Logical Limits," DRI's For The Defense (September 1998).
01.01.1998	Co-Author, "The Restatement (Third) of Torts and its Projected Impact upon Manufacturers of Prescription Drugs and Medical Devices," DRI Drug & Medical Device Committee (1998).
01.01.1995	Editor, "State-by-State Summary of Ex Parte Contacts With Treating Physicians," ABA (January 1995).
12.01.1992	"Unavoidably Unsafe Drugs, The Future of Comment K," DRI’s For The Defense (December 1992).

Speaking Engagements

Nanotechnology: It Really Is a Small World
DRI Annual Drug & Medical Device Seminar
Chicago, Illinois, May 6, 2011
38th Annual Trial Academy of the
International Association of Defense Counsel (IADC)
Faculty Member
Palo Alto, California, July 31-August 6, 2010
Defenses in Drug & Medical Device Litigation
DRI Drug & Device Committee
Young Lawyers Seminar
Chicago, Illinois, September 12, 2012
Chicago, Illinois, September 29, 2010
Chicago, Illinois, September 23, 2008
Chicago, Illinois, September 25, 2007
ABA Section of Litigation
Environmental, Mass Torts and Product Liability Committees
Joint CLE Seminar
Program Co-Chair and Moderator
Snowbird, Utah, January 11, 2007
Current Issues in Pharmaceutical Litigation & Policy
ABA Products Liability Committee
Program Co-Chair
Pfizer, November 18, 2005
Johnson & Johnson, November 8, 2004
GlaxoSmithKline, November 20, 2003
Sanofi-Aventis, November 7, 2002
How Can We Tell If We’re Winning?
Mass Tort Insight from The Inside
Program Co-Chair and Moderator
DRI Annual Meeting
Chicago, Illinois, October 5, 2001
Daubert Challenges in Florida State Court
FDLA Winter Seminar
Snowmass, Colorado, January 27, 2000
Lessons Learned from Real Mass Tort Litigation
Program Co-Chair
ABA Litigation Section Annual Meeting
Dallas, Texas, April 16-17, 1999
Defending Industrywide Litigation in the 21st Century
Program Chair
DRI Industrywide Litigation Seminar
New Orleans, Louisiana, February 25-26, 1999

Professional Recognition

National Board of Trial Advocates, Certified Civil Pretrial Practice Advocate
National Board of Civil Pretrial Practice Advocacy, Certified Pretrial Attorney
AV Rated by Martindale-Hubbell
Listed in Chambers USA Guide to America’s Leading Business Lawyers (Litigation) (since 2007)
Listed in Best Lawyers in America (since 2005) (recognized for Bet-the-Company Litigation, Commercial Litigation, Mass Tort Litigation, and Product Liability Litigation)
Listed in the International Who’s Who of Product Liability Defense Lawyers (one of six Florida Lawyers)
Listed in the International Who's Who of Business Lawyers
Selected for inclusion in Guide to the World’s Leading Product Liability Lawyers
Selected for inclusion in Florida Super Lawyers, Product Liability Defense (2006 - 2012)

Professional and Civic Activities

American Board of Trial Advocates
President, Tampa Bay Chapter (2012)
Thirteenth Circuit Judicial Nominating Commission
Chair (2011-2012)
Appointed by Governor Crist (2008)
International Association of Defense Counsel
Member, Trial Academy Faculty (2010)
Fellow of the American Bar Foundation
Product Liability Advisory Council
Defense Research Institute
Drug & Medical Device Committee, Steering Committee, Member (1992-present)
Industrywide Litigation Committee, Chair (1999-2001)
J. Clifford Cheatwood Inn of Court, Member
Florida Defense Lawyers Association
Board of Directors (1995-2000)
American Bar Association
Litigation Section, Product Liability Committee
Co-Chair, Pharmaceutical Subcommittee (1995-1999)